Video Experimental Relacionado
Updated: Jul 11, 2026
07:50
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Completeza de los informes de seguridad en ensayos aleatorizados: una evaluación de 7 áreas médicas
1Clinical Trials and Evidence-Based Medicine Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
JAMA
|March 10, 2001
Resumen
Los informes de seguridad en ensayos aleatorizados a menudo son inadecuados. Este estudio encontró una variación significativa en la forma en que se informan los efectos adversos y las interrupciones del tratamiento debido a la toxicidad, lo que hace necesario revisar las normas.
Área de la Ciencia:
- La investigación clínica es la investigación clínica.
- Farmacovigilancia y farmacovigilancia también.
- Estadísticas Médicas Estadísticas Médicas
Sus antecedentes:
- Los ensayos aleatorios son cruciales para evaluar la seguridad de los nuevos medicamentos.
- Sin embargo, los datos completos sobre los informes de seguridad de los medicamentos en estos ensayos siguen siendo limitados.
Objetivo del estudio:
- Evaluar la integridad y la calidad de los informes de seguridad en ensayos clínicos aleatorios de medicamentos.
- Identificar los factores que influyen en el alcance de los informes de seguridad.
Principales métodos:
- Una encuesta de 192 ensayos clínicos aleatorios de fármacos en 7 áreas médicas.
- El análisis se centró en la presentación de informes de efectos adversos, toxicidad y interrupciones del tratamiento.
- Examinó la asignación de espacio para los datos de seguridad y sus predictores.
Principales resultados:
- La definición adecuada de la gravedad y la toxicidad de los efectos adversos se encontró en solo el 39% y el 29% de los ensayos, respectivamente.
- Menos de la mitad (46%) de los ensayos informaron razones específicas para la interrupción del tratamiento debido a la toxicidad.
- Los informes de seguridad variaron significativamente en diferentes temas médicos y diseños de estudio.
Conclusiones:
- La calidad y cantidad de informes de seguridad en ensayos aleatorios son generalmente insuficientes.
- Existen diferencias significativas en los informes de seguridad en todos los campos médicos y las características de los ensayos.
- Las normas actuales para la presentación de informes de seguridad requieren una revisión para garantizar una presentación adecuada de los datos.
Videos de Conceptos Relacionados
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:21Types of Reports II: Incident or Occurrence Report
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...